94 related articles for article (PubMed ID: 16180961)
21. Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
Meltzer HY
J Clin Psychiatry; 2001; 62 Suppl 27():35-9; discussion 40-1. PubMed ID: 11806488
[TBL] [Abstract][Full Text] [Related]
22. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
23. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
Silvestre JS; Prous J
Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
[TBL] [Abstract][Full Text] [Related]
24. Safety and tolerability of antipsychotic treatment in young patients with schizophrenia.
Correll CU
J Clin Psychiatry; 2011 Aug; 72(8):e26. PubMed ID: 21899814
[TBL] [Abstract][Full Text] [Related]
25. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
Chan J; Sweeting M
J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
[TBL] [Abstract][Full Text] [Related]
26. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
Vohora D
Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
[TBL] [Abstract][Full Text] [Related]
27. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial.
Nasrallah HA
J Clin Psychiatry; 2007; 68 Suppl 1():5-11. PubMed ID: 17286522
[TBL] [Abstract][Full Text] [Related]
28. [Use of antipsychotics in first line].
Stefos G
Rev Med Brux; 2004 Sep; 25(4):A302-7. PubMed ID: 15516061
[TBL] [Abstract][Full Text] [Related]
29. Metabolic side effects of atypical antipsychotics in children: a literature review.
Fedorowicz VJ; Fombonne E
J Psychopharmacol; 2005 Sep; 19(5):533-50. PubMed ID: 16166191
[TBL] [Abstract][Full Text] [Related]
30. Treatment-emergent adverse events associated with atypical antipsychotics.
Cha DS; McIntyre RS
Expert Opin Pharmacother; 2012 Aug; 13(11):1587-98. PubMed ID: 22304541
[TBL] [Abstract][Full Text] [Related]
31. Drug treatments for schizophrenia - past, present and future.
Rasmussen JG
Int J Psychiatry Clin Pract; 1997; 1(4):227-30. PubMed ID: 24946188
[TBL] [Abstract][Full Text] [Related]
32. A review of the effect of atypical antipsychotics on weight.
Nasrallah H
Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():83-96. PubMed ID: 12504074
[TBL] [Abstract][Full Text] [Related]
33. Factors in antipsychotic drug selection: tolerability considerations.
Nasrallah HA
CNS Spectr; 2003 Nov; 8(11 Suppl 2):23-5. PubMed ID: 14978455
[TBL] [Abstract][Full Text] [Related]
34. Atypicality of atypical antipsychotics.
Farah A
Prim Care Companion J Clin Psychiatry; 2005; 7(6):268-74. PubMed ID: 16498489
[TBL] [Abstract][Full Text] [Related]
35. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management.
Chue P; Kovacs CS
Bipolar Disord; 2003; 5 Suppl 2():62-79. PubMed ID: 14700015
[TBL] [Abstract][Full Text] [Related]
36. Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder.
Bishara D; Taylor D
Neuropsychiatr Dis Treat; 2009; 5():483-90. PubMed ID: 19851515
[TBL] [Abstract][Full Text] [Related]
37. The pharmaco-economics of atypical antipsychotics.
Taylor D; Aitchison K
Int J Psychiatry Clin Pract; 1999; 3(4):237-48. PubMed ID: 24921226
[TBL] [Abstract][Full Text] [Related]
38. Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.
Slim M; Medina-Caliz I; Gonzalez-Jimenez A; Cabello MR; Mayoral-Cleries F; Lucena MI; Andrade RJ
Drug Saf; 2016 Oct; 39(10):925-43. PubMed ID: 27449495
[TBL] [Abstract][Full Text] [Related]
39. Do atypical antipsychotics improve cognition?
Walters Y; Agius M
Psychiatr Danub; 2014 Nov; 26 Suppl 1():285-8. PubMed ID: 25413554
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
